UPDATE: Stryker Biotech Indicted Over Product Promotion

It's a tiny business for Stryker, but one that has had problems over the years, including a Food and Drug Administration panel's rejection in March of Stryker's bid to use 'Op-1' bone-growth products more broadly. They are only approved in the U.S. today...